China's biotech industry: An Asian dragon is growing

Backed by a government intent on promoting innovation and fuelled by the “brain gain” of talented scientists and entrepreneurs returning from abroad, China’s health biotech industry only needs a more favourable investment climate to emerge as a global force in the production of therapies and medicines – both new and low-cost generics – experts say in a new study.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news118940809.html">China's biotech industry: An Asian dragon is growing</a></p> <p>Backed by a government intent on promoting innovation and fuelled by the “brain gain” of talented scientists and entrepreneurs returning from abroad, China’s health biotech industry only needs a more favourable investment climate to emerge as a global force in the production of therapies and medicines – both new and low-cost generics – experts say in a new study.</p>